Background
Assessment of age‐associated disorders has become increasingly important.
Methods
In a clinical setting, people with intellectual disability with and without dementia were assessed retrospectively using the Neuropsychological Test Battery (NTB) and the Dementia Questionnaire for People with Learning Disabilities (DLD) at two different times to analyse neuropsychological changes and diagnostic validity. One group (n = 44) was assessed with both instruments, while the DLD was applied in 71 patients.
Results
In the NTB (n = 44), only patients with dementia (n = 26) showed a decline in the NTB total score and three subscales. Receiver operating characteristic analysis revealed a diagnostic sensitivity of .67, a specificity of .81, and an area under the curve (AUC) of .767. In the DLD group (n = 71), only those with dementia displayed a decrease in the cognitive and social scale; diagnostic sensitivity and specificity values were low (.61/.63) and the AUC was .704.
Conclusions
Neuropsychological assessment was sensitive to detect cognitive changes over time. Sensitivity values of both instruments suggest a reassessment at a later time point.
Zusammenfassung
Ziel Erfassung von Differenzialdiagnosen (DD) und Komorbiditäten
bei Erwachsenen mit Autismusverdacht, Überprüfung des Autismus
Quotient (AQ) auf seine Eignung für das Screening.
Methode Stichprobe N=106; ROC-Analyse des AQ gegen das klinische
Expertenurteil.
Ergebnisse Komorbide affektive Störungen in beiden Gruppen
(48%), DD waren Angst- (33%) und
Persönlichkeitsstörungen (22%). AQ: AUC=0,527,
Sensitivität/Spezifität von
70%/35%.
Schlussfolgerungen Erwachsene mit Autismusverdacht sind durch DD und
Komorbiditäten hoch belastet. Der AQ ist für das Screening nicht
geeignet.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.